Plegridy (Peginterferon Beta-1A)
Brand: Plegridy
Active Ingredient(s): Peginterferon Beta-1A
Strength: 125 mcg – 63 mcg / 94 mcg
Pack Size: 2 units – 2 units Prefilled Syringe
Store in the refrigerator.
DIN: 02444399 – 02444402
Manufacturer: Biogen Canada Inc. (Canada)
Alternatives:
*A valid prescription is required for Rx items.
Description
Plegridy (Peginterferon Beta-1A) is a biological response modulator agent. It is typically used for the treatment of patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Multiple sclerosis (MS) is a chronic and disabling disease caused by the body’s own defense system attacking and destroying the protective covering (myelin) surrounding nerve fibres. Interferon beta-1a works by slowing down the attack of the body’s defense cells on the nerves. It may also have other uses.
Additional information
Plegridy (Peginterferon Beta-1A) is typically used every 14 days beginning on day 29 (maintenance). However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Your nurse will administer Plegridy (Peginterferon Beta-1A) for you into a muscle or under the skin. Self-injection: Administer intramuscularly (into a muscle) in the thigh, rotate injection sites between left and right thigh, or administer under the skin in the abdomen, back of the upper arm, or thigh, rotate injection sites, do not inject into area where skin is red, irritated, bruised, infected, or scarred. WARNING: Depression, suicidal ideation and suicide have been reported, monitor for symptoms of depression and suicidal ideation, consider discontinuing treatment with development of depression or other severe psychiatric symptoms. In addition to its desired action, Plegridy (Peginterferon Beta-1A) may cause some side effects, notably: It may cause flu-like symptoms (e.g., headache, muscle aches, chills or fever) It may cause headaches, increased body temperature It may cause itchy skin, joint or muscle pain Contraindications: Hypersensitivity to natural or recombinant interferon beta or peginterferon, or any component of the formulation. Taking Plegridy (Peginterferon Beta-1A) during pregnancy may be harmful for the baby. Women of childbearing potential should use an effective contraceptive method. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. A treatment with Plegridy (Peginterferon Beta-1A) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Plegridy (Peginterferon Beta-1A)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews